Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT06921902

Glycemic Metrics and Patterns in People With and Without Prediabetes

Led by Abbott Diabetes Care · Updated on 2026-04-09

2000

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

CONDITIONS

Official Title

Glycemic Metrics and Patterns in People With and Without Prediabetes

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject must be at least 18 years of age.
  • Subject must be willing and able to provide written signed and dated informed consent.
Not Eligible

You will not qualify if you...

  • Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
  • Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
  • Subject is known to be pregnant at the time of enrollment.
  • Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
  • Subject is currently on any form of treatment indicated for the treatment of diabetes.
  • Subject is currently on any form of medication indicated for weight loss.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Diabetes and Obesity Care

Bend, Oregon, United States, 97702

Actively Recruiting

Loading map...

Research Team

M

MOHAMED NADA, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here